Sedia Biosciences is a privately held medical device and diagnostics company founded in 2009 and based in Portland Oregon. Our commitment is to become a leader in three areas intended to advance global access to care as reflected by our: (1) expertise in rapid point of care diagnostic assays, especially alternative fluid (e.g. oral, urine, etc) assays, (2) scientific and market leadership in novel HIV epidemiological disease incidence assays and other public health tools and (3) novel clinical specimen collection devices to improve and facilitate remote collection of specimens for follow-up testing. Sedia brings together a dedicated team of researchers, scientists and business people that share our common mission and develops, manufactures and licenses these technology and products to improve access to medical care around the world.